Exploring the role of artificial intelligence in early cancer detection
Two new Review articles in the peer-reviewed journal AI in Precision Oncology explore the role of artificial intelligence (AI) in...
Insilico Medicine develops novel PTPN2/N1 inhibitor for cancer immunotherapy using generative AI
In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade, has made remarkable advances. But while immunotherapy...
Duke-NUS scientists uncover key resistance mechanism to Wnt inhibitors in pancreatic and colorectal cancers
Scientists at Duke-NUS Medical School have uncovered why some pancreatic and colorectal cancers fail to respond to Wnt inhibitors, a...
Study lays the basis for new knowledge on gastrointestinal diseases
The meeting point of the stomach and esophagus, the so-called gastro-esophageal junction, is a region of the human body that...
Next-gen lab chip transforms cancer detection: triple-threat cell sorting unveiled
Researchers have unveiled a microfluidic device that significantly improves the separation of tumor cells and clusters from malignant effusions. This...
Laura Soucek receives an ERC Advanced Grant to maximize the clinical and preclinical use of the first viable MYC inhibitor
Laura Soucek, an ICREA Research Professor, Director of VHIO’s Experimental Therapeutics Program, and Head of our Models of Cancer Therapies...
NCCN 2024 Annual Conference shares cancer care updates for practical, immediate use in practice
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—hosted more than 1,700 oncology professionals...
Groundbreaking treatment approach shows promise in hard-to-treat cancers
MIAMI (April 11, 2024) – Researchers have developed a functional precision medicine approach that targets cancer by combining genetic testing with...
Colorless, odorless gas likely linked to alarming rise in non-smoking lung cancer
COLUMBUS, Ohio – Although lung cancer is traditionally thought of as a “smoker’s disease,” a surprising 15-20% of newly diagnosed...
Exploring the role of MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia
“Our results reveal that MIA-602 may be a useful treatment for Doxorubicin-resistant AML ”Credit: 2024 Gaumond et al. “Our results...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!